[1]刘可佳,徐 帅,李娟娟,等.基于“人卧血归于肝”探讨睡眠障碍对代谢相关脂肪性肝病的影响[J].陕西中医,2023,(6):758-761.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.017]
　LIU Kejia,XU Shuai,LI Juanjuan,et al.The influence of sleep disorders on metabolic associated fatty liver disease based on “the blood flows back to the liver when the man lies down”[J].,2023,(6):758-761.[doi:DOI:10.3969/j.issn.1000-7369.2023.06.017]
点击复制

基于“人卧血归于肝”探讨睡眠障碍对代谢相关脂肪性肝病的影响
分享到：

《陕西中医》[ISSN:1000-7369/CN:61-1281/TN]

卷:
期数:
2023年6期
页码:
758-761
栏目:
学术探讨
出版日期:
2023-06-05

文章信息/Info

Title:
The influence of sleep disorders on metabolic associated fatty liver disease based on “the blood flows back to the liver when the man lies down”
作者:
刘可佳1; 徐 帅1; 李娟娟1; 刘宝山1; 赵静洁1; 2
(1.首都医科大学附属北京友谊医院,北京 100050; 2.首都医科大学中西医结合代谢相关脂肪性肝病诊疗与研究中心,北京 100050)
Author(s):
LIU Kejia; XU Shuai;  LI Juanjuan;  LIU Baoshan; ZHAO Jingjie
(Beijing Friendship Hospital,Capital Medical University,Beijing 100050,China)
关键词:
代谢相关脂肪性肝病;  睡眠障碍;  中枢系统;  免疫系统;  内分泌系统;  肠道菌群
Keywords:
Metabolic associated fatty liver disease;  Sleep disorders;  Central nerves system;  Immune system;  Endocranium system;  Gut microbiota
分类号:
R 589.2
DOI:
DOI:10.3969/j.issn.1000-7369.2023.06.017
文献标志码:
A
摘要:
“人卧血归于肝”是睡眠与“肝”藏象功能的重要关联,也是肝主藏血、肝主疏泄的具体体现。现基于“人卧血归于肝” 梳理睡眠与“肝”藏象的必然联系,总结睡眠障碍对肝脏糖脂代谢紊乱的影响,指出睡眠障碍通过中枢调控系统引发进食异常从而增加肝脏代谢负担,并通过其诱发的免疫反应加重肝脏代谢紊乱和肝脏炎症,也可增加胰岛素抵抗引发糖脂代谢异常并增加肝脏脂肪堆积。除此以外,睡眠障碍还可通过影响肠道菌群的变化对脂肪的消化吸收促进肝脏脂肪变性。故以“人卧血归于肝”的理论引出睡眠对于肝脏疾病的重要作用,并以期为进一步探索中西医结合防治方案提供理论参考。
Abstract:
“The blood flows back to the liver when the man lies down” is an important correlation between sleep disorders and the function of “liver” in traditional Chinese medicine(TCM),and it is also an expression of the “liver's” role in storing blood and the lier goerns free coursing.The article summarizes the inevitable relationship between sleep disorders and the “liver” in TCM based on the principle that “blood flows back to the liver when the man lies down ”.According to modern research,it is found that sleep disorders have an impact on the liver metabolism disorder.It is believed that sleep disorders increase the burden of liver metabolism by causing abnormal eating through the central nerves system,the immune system,the endocranium system and the gut microbiota.Modern clinical practice is guided by the theory of “the blood flows back to the liver when the man lies down”,which provides theoretical reference for the diagnosis and treatment views of integrated traditional Chinese and western medicine.

参考文献/References:

[1] 李紫健,牛建海,刘文英,等.基于“血气不和,百病乃变化而生”理论运用通法治疗脂肪肝[J].陕西中医,2022,43(10):1436-1438,1441.
[2] Zhou J,Zhou F,Wang W,et al.Epidemiological features of NAFLD from 1999 to 2018 in China[J].Hepatology,2020,71(5):1851-1864.
[3] Estes C,Anstee QM,Arias LM,et al.Modeling NAFLD disease burden in China,France,Germany,Italy,Japan,Spain,United Kingdom,and United States for the period 2016-2030[J].Hepatology,2018,69(4):896-904.
[4] 孙海燕.非酒精性脂肪肝患者血生化指标、饮食及行为特征研究[J].华南预防医学,2020,46(6):605-608.
[5] Marin AB,Abete I,Cantero I,et al.Association between sleep disturbances and liver status in obese subjects with nonalcoholic fatty liver disease:A comparison with healthy controls[J].Nutrients,2019,11(2):322.
[6] 吕佳慧,李晓飞,郭莲怡.代谢相关脂肪性肝病与睡眠障碍的关系[J].临床肝胆病杂志,2021,37(12):2854-2860.
[7] Eslam M,Newsome PN,Anstee QM,et al.A new definition for metabolic associated fatty liver disease:An international expert consensus statement[J].Journal of Hepatology,2020,73(1):202-209.
[8] Knutson KL.Sleep duration and cardiometabolic risk:A review of theepidemiologic evidence[J].Best Pract Res Clin Endocrinol Metab,2010,24(5):731-743.
[9] Yang J,Luo S,Li R,et al.Sleep factors in relation to metabolic dysfunction associated fatty liver disease in middle-aged and elderly Chinese[J].J Clin Endocrinol Metabolism,2022,7(28):428.
[10] Jin UY,Yoosoo C,Suk JH,et al.Decrease in sleep duration and poor sleep quality over time is associated with an increased risk of incident non-alcoholic fatty liver disease[J].Journal of Personalized Medicine,2022,12(1):92.
[11] 修 莹,樊 旭.从“肝藏血”理论探讨寤寐[J].亚太传统医药,2017,13(20):51-52.
[12] Fan H,Liu ZQ,Zhang X,et al.Investigating the association between seven sleep traits and nonalcoholic fatty liver disease:Observational and mendelian randomization study[J].Frontiers in Genetics,2022,17(13):792558.
[13] Christine B,Diego MW,Marlon OP,et al.Sleep disruption and daytime sleepiness correlating with disease severity and insulin resistance in non-alcoholic fatty liver disease:A comparison with healthy controls[J].PLoS One,2015,10(11):143293.
[14] Krolow GK,Garcia E,Schoor F,et al.Obstructive sleep apnea and severity of nonalcoholic fatty liver disease[J].European Journal of Gastroenterology & Hepatology,2021,33(8):1104-1109.
[15] 张珊珊,贺 君,林彦廷,等.“胃不和则卧不安”治疗失眠机制探讨[J].陕西中医,2021,42(5):625-628.
[16] Michal M,Wiltink J,Kirschner Y,et al.Complaints of sleep disturbances are associated with cardiovascular disease:Results from the gutenberg health study[J].PLoS One,2014,9(8):104324.
[17] Bhutani S,Howard JD,Reynolds R,et al.Olfactory connectivity mediates sleep-dependent food choices in humans[J].eLife,2019,8(8):49053.
[18] Huang WY,Zou X,Lu FE,et al.Jiao-tai-wan up-regulates hypothalamic and peripheral circadian clock gene cryptochrome and activates PI3K/AKT signaling in partially sleep-deprivedrats[J].Curr Med Sci,2018,38:704-713.
[19] Matsumoto H,Okazaki S,Katada R.Disfunction of endosome prevents developing alcoholic fatty liver disease via inhibition of TLR4,TLR7,and TLR9 signaling pathways [J].FASEB J,2013,27(1):387.
[20] 石礼静,刘弘毅,孔一帆,等.Lipin-1与胰岛素抵抗关系研究进展[J].陕西医学杂志,2020,49(12):1699-1702.
[21] 杨 刚,黄 康.下丘脑-垂体-肾上腺轴的功能检测对肝郁症与老年糖尿病患者的睡眠障碍的影响分析[J].临床检验杂志:电子版,2019,8(4):86.
[22] Klingenberg L,Chaput JP,Holmback U,et al.Acute sleep restriction reduces insulin sensitivity in adolescent boys[J].Sleep,2013,36(7):1085-1090.
[23] Broussard JL,Ehrmann DA,Van Cauter E,et al.Impaired insulin signaling in human adipocytes after experimental sleep restriction:A randomized,crossover study[J].Ann Intern Med,2012,157(8):549-557.
[24] 中华医学会肝病学分会脂肪肝和酒精性肝病学组,中国医师协会脂肪性肝病专家委员会.非酒精性脂肪性肝病防治指南(2018年更新版)[J].临床肝胆病杂志,2018,34(5):947-957.
[25] 刘应莉,王艳荣,张秋瓒.肠道菌群-过氧化物酶体增殖物激活受体信号通路及其在代谢相关脂肪性肝病发病中的作用研究进展[J].陕西医学杂志,2021,50(9):1166-1169.
[26] Benedict C,Vogel H,Jonas W,et al.Gut microbiota and glucometabolic alterations in response to recurrent partial sleep deprivation in normal-weight young individuals[J].Molecular Metabolism,2016,5(12):1175-1186.
[27] Poroyko VA,Carreras A,Khalyfa A,et al.Chronic sleep disruption alters gut microbiota,induces systemic and adipose tissue inflammation and insulin resistance in mice[J].Scientific Reports,2016,14(6):35405.
[28] 肖 丽,杨 玲.肠道菌群与非酒精性脂肪性肝病的关系[J].临床肝胆病杂志,2017,33(4):774-779.
[29] Fei N,Bruneau A,Zhang XJ,et al.Endotoxin producers overgrowing in human gut microbiota as the causative agents for nonalcoholic fatty liver disease[J].mBio,2020,11(1):3219-3263.
[30] Hoyles L,Fernandez RJ,Federici M,et al.Molecular phenomics and metagenomics of hepatic steatosis in non-diabetic obese women[J].Nature Medicine,2018,24(7):1070-1080.

相似文献/References:

[1]魏明娜,朱建贵.血府逐瘀汤联合劳拉西泮治疗老年2型心肾综合征稳定期伴有睡眠障碍临床研究[J].陕西中医,2021,(4):438.[doi:DOI:10.3969/j.issn.1000-7369.2020.04.008]
[2]宋 杰,杨言府.益肾宁心汤加减治疗帕金森病合并睡眠障碍临床研究[J].陕西中医,2021,(6):747.[doi:DOI:10.3969/j.issn.1000-7369.2020.06.017]
[3]王艳英,马 堃.六味地黄汤联合逍遥散加减治疗肾虚肝郁型围绝经期睡眠障碍临床研究[J].陕西中医,2023,(5):584.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.009]
　WANG Yanying,MA Kun.Clinical study on Liuwei Dihuang decoction combined with modified Xiaoyao powder in the treatment of perimenopausal sleep disorder of kidney deficiency and liver depression[J].,2023,(6):584.[doi:DOI:10.3969/j.issn.1000-7369.2023.05.009]
[4]石丹丹,艾碧琛,李木兰,等.基于FXR/SHP/PEPCK和FXR/ApoCⅡ通路探讨茵陈五苓散对代谢相关脂肪性肝病大鼠糖脂代谢的作用[J].陕西中医,2025,46(2):153.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.002]
　SHI Dandan,AI Bichen,LI Mulan,et al.Effects of Yinchen Wuling powder on glycolipid metabolism in metabolic associated fatty liver disease rats based on FXR/SHP/PEPCK and FXR/ApoCⅡ pathways[J].,2025,46(6):153.[doi:DOI:10.3969/j.issn.1000-7369.2025.02.002]

备注/Memo

备注/Memo:
基金项目:国家自然科学基金资助项目(82004109); 首都卫生发展科研专项课题(首发 2022-2-20213)
更新日期/Last Update: 2023-06-09